Valeo Pharma (VPH.C) announced they have entered into a Product Listing Agreement (PLA) with the Executive Officer of the Ontario Public Drug Program for the listing of Redesca and…
VPH.C
Radio and TV personality, Jody Vance, speaks with Steve Saviuk, president and CEO of Valeo Pharma (VPH.C) to get updates on the company’s latest achievements and future goals. Disclaimer:…
Valeo Pharma (VPH.C) announced they have begun shipments across Canada of Redesca and Redesca HP, their low molecular weight heparin (LMWH) biosimilar. Valeo has licensed Redesca from Shenzhen Techdow…
Valeo Pharma (VPH.C) has announced a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units a a price of $1000 per unit for maximum gross proceeds of…
Radio and TV personality, Jody Vance, speaks with Steve Saviuk, president and CEO of Valeo Pharma (VPH.C) to get a close look at the company and it’s product pipeline…
“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement…
Jody Vance once again dives deeper into some of small caps most interesting stories. In this episode, Jody speaks with Valeo Pharma (VPH.C) president and CEO, Steve Saviuk, to…
In Episode 2 of Invest or Not to Invest we take a look at Valeo Pharma (VPH.C). They are a Canadian pharmaceutical company whose stock rose over 200% in…
Unless you’ve been living under a rock, you know that Covid-19 took a sledgehammer to corporate profits this summer. So, what the hell did you expect from Valeo Pharma’s…
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it…